These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17218104)

  • 1. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
    Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
    Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
    Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
    Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
    Blume A; Neubacher B; Thiem J; Peters T
    Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Virtual Screening of New Benzoic Acid Derivatives as Trypanosoma cruzi Trans-sialidase Inhibitors.
    Vázquez-Jiménez LK; Paz-González AD; Juárez-Saldivar A; Uhrig ML; Agusti R; Reyes-Arellano A; Nogueda-Torres B; Rivera G
    Med Chem; 2021; 17(7):724-731. PubMed ID: 32370720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
    Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
    Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J; Bryce RA; Douglas KT
    Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
    Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
    Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.
    Buchini S; Buschiazzo A; Withers SG
    Angew Chem Int Ed Engl; 2008; 47(14):2700-3. PubMed ID: 18300214
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous fluorimetric assay for high-throughput screening of inhibitors of trans-sialidase from Trypanosoma cruzi.
    Neres J; Buschiazzo A; Alzari PM; Walsh L; Douglas KT
    Anal Biochem; 2006 Oct; 357(2):302-4. PubMed ID: 16930524
    [No Abstract]   [Full Text] [Related]  

  • 10. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
    Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
    Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
    Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
    Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
    Meinke S; Schroven A; Thiem J
    Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
    Giorgi ME; de Lederkremer RM
    Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
    Miller BR; Roitberg AE
    Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile.
    Watts AG; Damager I; Amaya ML; Buschiazzo A; Alzari P; Frasch AC; Withers SG
    J Am Chem Soc; 2003 Jun; 125(25):7532-3. PubMed ID: 12812490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.
    Chand P; Kotian PL; Morris PE; Bantia S; Walsh DA; Babu YS
    Bioorg Med Chem; 2005 Apr; 13(7):2665-78. PubMed ID: 15755666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
    Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
    Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
    Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
    J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
    Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
    J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.